Where are you?
To give you the most accurate information about our products and what we can do for you, we need to direct you to the right site.
USA
International
Media and Investors Resources
Press Release, 18 October 2018
Kuros Biosciences advances its Fibrin-PTH (KUR-113) spinal fusion product candidate program
Press Release, 18 October 2018
Kuros Biosciences advances its Fibrin-PTH (KUR-113) spinal fusion product candidate program
Press Release, 27 September 2018
Kuros reports first patient treated in randomized controlled trial of MagnetOs in spinal fusion
Press Release, 27 September 2018
Kuros reports first patient treated in randomized controlled trial of MagnetOs in spinal fusion
Press Release, 25 September 2018
Kuros Biosciences appoints Strategic Advisory Board
Press Release, 25 September 2018
Kuros Biosciences appoints Strategic Advisory Board